Document Detail

Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock*.
MedLine Citation:
PMID:  22713217     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Controversial data are available on the effects of hydrogen sulfide during hemorrhage. Because the clinical significance of hydrogen sulfide administration in rodents may not be applicable to larger species, we tested the hypothesis whether intravenous Na2S (sulfide) would beneficially influence organ dysfunction during long-term, porcine hemorrhage and resuscitation.
DESIGN: Prospective, controlled, randomized study.
SETTING: University animal research laboratory.
SUBJECTS: Forty-five domestic pigs of either gender.
INTERVENTIONS: Anesthetized and instrumented animals underwent 4 hrs of hemorrhage (removal of 40% of the blood volume and subsequent blood removal/retransfusion to maintain mean arterial pressure at 30 mm Hg). Sulfide infusion was started 2 hrs before hemorrhage, simultaneously with blood removal or at the beginning of retransfusion of shed blood, and continued for 12 hrs. Resuscitation comprised hydroxyethyl starch and norepinenephrine infusion titrated to maintain mean arterial pressure at preshock values.
MEASUREMENTS AND MAIN RESULTS: Before, immediately at the end of and 12 and 22 hrs after hemorrhage, we measured systemic and regional hemodynamics (portal vein, hepatic and right kidney artery ultrasound flow probes) and oxygen transport, nitric oxide and cytokine production (nitrate+nitrite, interleukin-6, tumor necrosis factor-α levels). Postmortem biopsies were analyzed for histomorphology (hematoxylin and eosin staining) and DNA damage (terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling staining). The progressive kidney (creatinine levels, creatinine clearance), liver (transaminase activities, bilirubin levels), and cardiocirculatory (norepipnehrine requirements, troponin I levels) dysfunction was attenuated in the simultaneous treatment group only, which coincided with reduced lung, liver, and kidney histological damage. Sulfide reduced mortality, however, irrespective of the timing of its administration.
CONCLUSIONS: While the sulfide-induced protection against organ injury was only present when initiated simultaneously with blood removal, it was largely unrelated to hypothermia. The absence of sulfide-mediated protection in the pretreatment protocol may be due to the accumulation of sulfide during low flow states. In conclusion, sulfide treatment can be effective in hemorrhagic shock, but its effectiveness is restricted to a narrow timing and dosing window.
Hendrik Bracht; Angelika Scheuerle; Michael Gröger; Balázs Hauser; José Matallo; Oscar McCook; Andrea Seifritz; Ulrich Wachter; Josef A Vogt; Pierre Asfar; Martin Matejovic; Peter Möller; Enrico Calzia; Csaba Szabó; Wolfgang Stahl; Kerstin Hoppe; Bettina Stahl; Lorenz Lampl; Michael Georgieff; Florian Wagner; Peter Radermacher; Florian Simon
Related Documents :
3953817 - Pancreatic tissue oxygenation during secretory stimulation.
18454687 - Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by ...
6116837 - Influence of venous congestion on blood-lymph transport of fluid and large molecules in...
22047817 - Effects of sedation with acepromazine maleate and buprenorphine hydrochloride on femora...
6210457 - Regional myocardial blood flow and coronary vascular reserve in unanesthetized young ca...
18420367 - Real-time color-flow mri at 3 t using variable-density spiral phase contrast.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Critical care medicine     Volume:  40     ISSN:  1530-0293     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-20     Completed Date:  2012-09-25     Revised Date:  2013-05-08    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2157-67     Citation Subset:  AIM; IM    
Sektion Anasthesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum, Ulm, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bilirubin / metabolism
Creatinine / analysis
Hetastarch / pharmacology
Hydrogen Sulfide / pharmacology*
Infusions, Intravenous
Liver / metabolism
Norepinephrine / pharmacology
Plasma Substitutes / pharmacology
Random Allocation
Resuscitation / methods*
Shock, Hemorrhagic / drug therapy*
Transaminases / metabolism
Troponin I / blood
Reg. No./Substance:
0/Plasma Substitutes; 0/Troponin I; 51-41-2/Norepinephrine; 60-27-5/Creatinine; 635-65-4/Bilirubin; 7783-06-4/Hydrogen Sulfide; 9005-27-0/Hetastarch; EC 2.6.1.-/Transaminases
Comment In:
Crit Care Med. 2012 Jul;40(7):2255-6   [PMID:  22710225 ]
Erratum In:
Crit Care Med. 2013 Apr;41(4):e41
Note: Dosage error in article text

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: Role of platel...
Next Document:  Aims, educational and competence-based evaluation methods in the theoretical courses in the Danish m...